Humana (HUM) Cost of Revenue (2009 - 2026)

Humana's Cost of Revenue history runs 18 years deep, the most recent figure standing at $33.7 billion for Q1 2026.

• In Q1 2026, Cost of Revenue rose 27.03% year-over-year to $33.7 billion; the TTM figure through Mar 2026 stood at $118.0 billion (up 15.59% YoY), while the FY2025 annual figure was $110.8 billion, up 10.08% from the prior year.
• Cost of Revenue was $33.7 billion for Q1 2026 at Humana, up from $28.7 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $33.7 billion in Q1 2026 to a low of $18.4 billion in Q3 2022.
• Historically, Cost of Revenue has averaged $24.1 billion across 5 years, with a median of $25.0 billion in 2024.
• The sharpest annual moves came in 2025 and 2026: Cost of Revenue gained 5.62% in 2025, then rose 27.03% in 2026.
• A 5-year view of Cost of Revenue shows it stood at $18.6 billion in 2022, then rose by 22.6% to $22.8 billion in 2023, then gained by 11.41% to $25.4 billion in 2024, then increased by 13.16% to $28.7 billion in 2025, then rose by 17.36% to $33.7 billion in 2026.
• The last three Cost of Revenue figures came in at $33.7 billion (Q1 2026), $28.7 billion (Q4 2025), and $28.0 billion (Q3 2025), per Business Quant data.